Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
23847studies shown
Showing 9,421-9,432 of 23,847
Drug study icon
CompletedNCT00448630

An Observational Study On Metabolic Syndrome Parameters In Schizophrenia Patients Treated With Atypical Antipsychotics

This study exists to understand how this type of care holds up over time after the earliest research stage. Researchers are trying to understand what this type of care could change in day-to-day care and decision-making.

Multiple locations, including Kurttepe
SchizophreniaOtherFrom 18 Years to 55 Years
Countries
Türkiye
Sponsor
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Condition
Schizophrenia
Drug study icon
TerminatedNCT01894984

Risperidone Long-Acting Injection for schizophrenia

This study was terminated. It is testing Risperidone Long-Acting Injection for schizophrenia.

Location not clearly listed
SchizophreniaDrugFrom 18 Years to 65 Years
Countries
Sponsor
Xian-Janssen Pharmaceutical Ltd.
Condition
Schizophrenia
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.